|
1. Biologie
|
|
|
|
|
|
2.4 Etiologie - Portables, ondes e-m
|
|
|
|
3. Prévention
|
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.2 Pharma
|
|
|
|
Roche boosted by trial success with blood cancer drug [Reuters]
|
|
|
|
|
|
Clinical
trials with the new drug are important in deciding how well the Swiss
drugmaker is placed to fend off cheaper competition from so-called
biosimilar copies of Rituxan, which are likely to hit the market in the
next couple of years. Shares in Roche rose 3.4 percent at 0725 GMT,
outperforming a 0.4 percent higher European pharma index.
|
|
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
5.4 Traitements - Economie
|
|
|
NICE rejects pricey Lilly newcomer Portrazza [FiercePharma]
|
|
|
|
|
|
The
way NICE sees it, adding Portrazza (necitumumab) to chemo tandem
gemcitabine plus cisplatin would cost the NHS a lofty sum of between
£110,000 and £170,000 per quality adjusted life year gained--and the
cost is “likely to be towards the upper end of this range,” the watchdog
wrote.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
|
|
Teen cancer death rate causes alarm [BBC News]
|
|
|
|
|
|
Too
many teenagers and young adults are dying of some types of cancer, a
Europe-wide report warns. Their survival rates for cancers such as
leukaemia are much lower than in younger children, says a report in the
Lancet Oncology.
|
|
|
|
|
|
|
6.10 Politiques
|
|
|
Op-Ed Contributor: Obama’s Pointless Cancer ‘Moonshot’ [NY Times]
|
|
|
|
|
|
The
researchers know the science and its limitations, but there is no prize
for playing down expectations. The different actors are outbidding one
another for attention and funding, and for more than half a century the
public has been told that the cure is just around the corner.
|
|
|
|
|
|
|
6.6 Publications
|
|
|
Reproducibility: Crisis or Not? [In the Pipeline]
|
|
|
|
|
|
Interestingly,
chemists were among the most confidant in the literature of their own
field (physics and engineering as well). The medical literature was
considered by its own practicioners to be the least reliable, and I
think that order is probably about right.
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|